Related Experiment Video

Updated: Mar 23, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.6K

Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development

Yuliya V Katlinskaya1, Kanstantsin V Katlinski1, Qiujing Yu1

  • 1Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Cell Reports
|April 8, 2016
PubMed

Insights

Type I interferons (IFNs) are crucial for preventing oncogene-induced senescence and melanoma. Restoring IFN signaling suppresses melanoma progression, highlighting its tumor-suppressive role.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Oncogene activation triggers DNA damage responses and cell senescence.
  • Type I interferons (IFNs) play a critical role in oncogene-induced senescence.
  • IFN signaling deficiency in melanocytes leads to aggressive melanoma development.

Purpose of the Study:

  • To investigate the role of type I interferons (IFNs) in oncogene-induced senescence and melanoma development.
  • To explore the therapeutic potential of restoring IFN signaling in melanoma.

Main Methods:

  • Utilized melanocyte and melanoma cell lines with activated Braf.
  • Employed human melanoma patient data and mouse transplanted tumor models.
  • Investigated the role of IFN receptor IFNAR1 downregulation and its partial resistance.

Main Results:

  • IFN signaling-deficient melanocytes with activated Braf developed aggressive melanomas.
  • Restoration of IFN signaling in melanoma cells induced senescence and suppressed progression.
  • IFNAR1 downregulation was identified as a key mechanism of IFN pathway inactivation in melanoma.
  • Mice with partially resistant IFNAR1 mutants showed delayed melanoma development and reduced metastasis.
  • Partial IFNAR1 resistance improved response to BRAF and PD-1 inhibitors.

Conclusions:

  • Type I IFN signaling acts as a critical tumor-suppressive pathway in melanoma.
  • Targeting IFNAR1 downregulation may prevent metastatic disease and enhance melanoma therapies.
  • Restoring IFN signaling is a promising strategy for melanoma treatment.
Keywords:
BRAFinterferon receptormelanomametastasissenescencetype I interferon

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

3.0K
Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes10:03

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

10.3K

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.2K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

3.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

2.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K